High-affinity CD20-specific TCRs suitable for adoptive immunotherapy isolated from the allo-repertoire using reverse immunology

Molecular pathways associated with immune modulation and thalidomide analogues

Dendritic cell vaccination combined with CTLA4 blockade

mRNA-based cancer vaccines

Immuno-biological properties of human cancer stem cells

Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer

Sharing Indian perspectives on CRPC

The future of mCRPC treatment - expert discussion

Insights into mCRPC in China, Thailand and Indonesia - expert discussion

Cost constraints affect treatment decision-making in China and Singapore - expert discussion

mCRPC management in Taiwan - expert interview

Mechanisms of action and robotics in mCRPC